DS

Donna Skerrett

Paradigm Biopharmaceuticals Limited | Executive Director
Dr Donna Skerrett has more than 30 years' experience in transfusion medicine, cellular therapy, and transplantation. She brings a wealth of experience in medical, clinical, and regulatory affairs. Donna served previously as Chief Medical Officer at Mesoblast. She was Director of Transfusion Medicine and Cellular Therapy at Weill Cornell Medical Center in New York (2004 - 2011), and prior to that was Associate Director of Transfusion Medicine and Director of Stem Cell Facilities at Columbia University's New York-Presbyterian Hospital. She has previously chaired the New York State Council on Blood and Transfusion Services, and served on the Board of Directors of the Fox Chase Cancer Center in Philadelphia, PA, and is currently a member of the Board of Visitors of Lewis Katz School of Medicine at Temple University.

Company and Role

Company
Title
Tenure
Since
PAR
Paradigm Biopharmaceuticals Limited
  • Executive Director
3yrs, 9mthJul 2020

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PAR
Paradigm Biopharmaceuticals Limited
25/08/231,094,284N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PAR
Paradigm Biopharmaceuticals Limited
29/02/24
Issued
1,000,000$0.350$350,000As advised by the company
PAR
Paradigm Biopharmaceuticals Limited
25/01/22
Buy
375,000$1.890$708,750As advised by the company
PAR
Paradigm Biopharmaceuticals Limited
19/11/20
Buy
500,000$3.050$1,525,000As advised by the company